论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
复方磺胺甲恶唑单药维持治疗成功治愈 HIV 合并中枢神经系统诺卡菌属萜品诺卡菌感染 1 例报告及文献复习
Received 6 February 2025
Accepted for publication 16 April 2025
Published 12 May 2025 Volume 2025:18 Pages 2461—2467
DOI https://doi.org/10.2147/IDR.S520976
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Sandip Patil
Jingjing He,1 Shengkui Tan,2 Jiannan Lv3
1Department of Infection, Baise People’s Hospital, Baise, 533000, People’s Republic of China; 2Guangxi Clinical Medical Research Center for Hepatobiliary Diseases, Youjiang Medical University for Nationalities, Baise, 533000, People’s Republic of China; 3Guangxi Clinical Medical Research Center for Hepatobiliary Diseases, Department of Infection, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, 533000, People’s Republic of China
Correspondence: Shengkui Tan; Jiannan Lv, Email sktan2008@163.com; gxaidscc@163.com
Abstract: The Nocardia infection of the central nervous system (CNS) in HIV-positive individuals is difficult to diagnose and treat, often requiring a combination of at least two drugs during the maintenance phase. In this article, we report a case of CNS Nocardia terpenic infection in an AIDS patient diagnosed by cerebrospinal fluid targeted next-generation sequencing (tNGS), which was ultimately treated successfully with sulfamethoxazole monotherapy due to adverse drug reactions. Additionally, we reviewed the relevant literature to explore individualized treatment options for CNS Nocardia infections in patients with AIDS and to provide clinicians with evidence-based treatment recommendations.
Keywords: AIDS, Nocardia terpenica, central nervous system, tNGS, case report